Chief Head
pharmacovigilance
Biopartners GmbH
Montenegro
Dr. Axel Dehn has been the Head of Pharma Covigilance of QPPV at BioPartners GmbH since 2009 Dr. Dehn joined Biopartners in 2007 as Stufenplanbeauftragter (Germany) and Deputy QP-PV. He is responsible person for pharmacovigilance issues in Europe and World Wide. Prior to this he held various senior positions with preclinical, clincal and pharmacovigilance responsibilities in multinational companies like Schwarz Pharma AG and Solvay Pharmaceuticals GmbH where he gained substantial experience. Dr. Dehn holds a PhD from the Medical School in Hannover and a Masters degree from Tulane University, New Orleans, USA.
pharmacovigilance and Clinical